Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV002506217 | SCV002811730 | pathogenic | Polycystic kidney disease, adult type | 2022-04-30 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV000501268 | SCV000592800 | pathogenic | Polycystic kidney disease | no assertion criteria provided | clinical testing | The PKD1, p.Arg2392AlafsX228 variant was not identified in the literature nor was it identified in the dbSNP, the Exome Aggregation Consortium database (March 14 2016), Clinvitae, ClinVar, GeneInsight COGR, MutDB, ADPKD Mutation Database, PKD1-LOVD, or PKD1-LOVD 3.0 databases. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. The c.7174delC variant is predicted to cause a frameshift, which alters the protein amino acid sequence beginning at codon 2392 and leads to a premature stop codon 228 codons downstream. This alteration is then predicted to result in a truncated or absent protein and loss of function. Loss of function variants of the PKD1 gene are an established mechanism of disease in autosomal dominant polycystic kidney disease and is the type of variant expected to cause the disorder. In summary, based on the above information, this variant meets our laboratory’s criteria to be classified as pathogenic. |